Devi E. Nampiaparampil
Research Subjects
Devi E. Nampiaparampil has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Alan David Kaye
Department of Anesthesiology, Louisiana State University Health Shreveport, Shreveport, LA 71103, USA
2 shared publications - Joshua A. Hirsch
Neuroendovascular Program, Massachusetts General Hospital, Boston, Massachusetts, USA
2 shared publications - Laxmaiah Manchikanti
Pain Management Centers of America, Paducah, USA
2 shared publications - Sanjay Bakshi
Amer Soc Intervent Pain Phys, Paducah, KY USA
2 shared publications - Alaa Abd-Elsayed
Department of Anesthesiology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53726, USA
1 shared publication Amit Sharma
Amer Soc Intervent Pain Phys, Paducah, KY USA
1 shared publication
Latest Publications
- 1 August 2020
- Vol. 23 (4) , S183-S203
Triaging Interventional Pain Procedures During COVID-19 or Related Elective Surgery Restrictions: Evidence-Informed Guidance from the American Society of Interventional Pain Physicians (ASIPP)
Background: The COVID-19 pandemic has worsened the pain and suffering of chronic pain patients due to stoppage of "elective" interventional pain management and office visits across the United States. The reopening of America and restarting of interventional techniques and elective surgical procedures has started. Unfortunately, with resurgence in some states, restrictions are once again being imposed. In addition, even during the Phase II and III of reopening, chronic pain patients and interventional pain physicians have faced difficulties because of the priority selection of elective surgical procedures. Chronic pain patients require high intensity care, specifically during a pandemic such as COVID-19. Consequently, it has become necessary to provide guidance for triaging interventional pain procedures, or related elective surgery restrictions during a pandemic. Objectives: The aim of these guidelines is to provide education and guidance for physicians, healthcare administrators, the public and patients during the COVID-19 pandemic. Our goal is to restore the opportunity to receive appropriate care for our patients who may benefit from interventional techniques. Methods: The American Society of Interventional Pain Physicians (ASIPP) has created the COVID-19 Task Force in order to provide guidance for triaging interventional pain procedures or related elective surgery restrictions to provide appropriate access to interventional pain management (IPM) procedures in par with other elective surgical procedures. In developing the guidance, trustworthy standards and appropriate disclosures of conflicts of interest were applied with a section of a panel of experts from various regions, specialties, types of practices (private practice, community hospital and academic institutes) and groups. The literature pertaining to all aspects of COVID-19, specifically related to epidemiology, risk factors, complications, morbidity and mortality, and literature related to risk mitigation and stratification was reviewed. The evidence - informed with the incorporation of the best available research and practice knowledge was utilized, instead of a simplified evidence-based approach. Consequently, these guidelines are considered evidence-informed with the incorporation of the best available research and practice knowledge. Results: The Task Force defined the medical urgency of a case and developed an IPM acuity scale for elective IPM procedures with 3 tiers. These included urgent, emergency, and elective procedures. Examples of urgent and emergency procedures included new onset or exacerbation of complex regional pain syndrome (CRPS), acute trauma or acute exacerbation of degenerative or neurological disease resulting in impaired mobility and inability to perform activities of daily living. Examples include painful rib fractures affecting oxygenation and post-dural puncture headaches limiting the ability to sit upright, stand and walk. In addition, emergency procedures include procedures to treat any severe or debilitating disease that prevents the patient from carrying out activities of daily living. Elective procedures were considered as any condition that is stable and can be safely managed with alternatives. Limitations: COVID-19 continues to be an ongoing pandemic. When these recommendations were developed, different stages of reopening based on geographical regulations were in process. The pandemic continues to be dynamic creating every changing evidence-based guidance. Consequently, we provided evidence-informed guidance. Conclusion: The COVID-19 pandemic has created unprecedented challenges in IPM creating needless suffering for pain patients. Many IPM procedures cannot be indefinitely postponed without adverse consequences. Chronic pain exacerbations are associated with marked functional declines and risks with alternative treatment modalities. They must be treated with the concern that they deserve. Clinicians must assess patients, local healthcare resources, and weigh the risks and benefits of a procedure against the risks of suffering from disabling pain and exposure to the COVID-19 virus.
- 1 August 2020
- Vol. 23 (4) , S183-S203
Triaging Interventional Pain Procedures During COVID-19 or Related Elective Surgery Restrictions: Evidence-Informed Guidance from the American Society of Interventional Pain Physicians (ASIPP)
Background: The COVID-19 pandemic has worsened the pain and suffering of chronic pain patients due to stoppage of "elective" interventional pain management and office visits across the United States. The reopening of America and restarting of interventional techniques and elective surgical procedures has started. Unfortunately, with resurgence in some states, restrictions are once again being imposed. In addition, even during the Phase II and III of reopening, chronic pain patients and interventional pain physicians have faced difficulties because of the priority selection of elective surgical procedures. Chronic pain patients require high intensity care, specifically during a pandemic such as COVID-19. Consequently, it has become necessary to provide guidance for triaging interventional pain procedures, or related elective surgery restrictions during a pandemic. Objectives: The aim of these guidelines is to provide education and guidance for physicians, healthcare administrators, the public and patients during the COVID-19 pandemic. Our goal is to restore the opportunity to receive appropriate care for our patients who may benefit from interventional techniques. Methods: The American Society of Interventional Pain Physicians (ASIPP) has created the COVID-19 Task Force in order to provide guidance for triaging interventional pain procedures or related elective surgery restrictions to provide appropriate access to interventional pain management (IPM) procedures in par with other elective surgical procedures. In developing the guidance, trustworthy standards and appropriate disclosures of conflicts of interest were applied with a section of a panel of experts from various regions, specialties, types of practices (private practice, community hospital and academic institutes) and groups. The literature pertaining to all aspects of COVID-19, specifically related to epidemiology, risk factors, complications, morbidity and mortality, and literature related to risk mitigation and stratification was reviewed. The evidence - informed with the incorporation of the best available research and practice knowledge was utilized, instead of a simplified evidence-based approach. Consequently, these guidelines are considered evidence-informed with the incorporation of the best available research and practice knowledge. Results: The Task Force defined the medical urgency of a case and developed an IPM acuity scale for elective IPM procedures with 3 tiers. These included urgent, emergency, and elective procedures. Examples of urgent and emergency procedures included new onset or exacerbation of complex regional pain syndrome (CRPS), acute trauma or acute exacerbation of degenerative or neurological disease resulting in impaired mobility and inability to perform activities of daily living. Examples include painful rib fractures affecting oxygenation and post-dural puncture headaches limiting the ability to sit upright, stand and walk. In addition, emergency procedures include procedures to treat any severe or debilitating disease that prevents the patient from carrying out activities of daily living. Elective procedures were considered as any condition that is stable and can be safely managed with alternatives. Limitations: COVID-19 continues to be an ongoing pandemic. When these recommendations were developed, different stages of reopening based on geographical regulations were in process. The pandemic continues to be dynamic creating every changing evidence-based guidance. Consequently, we provided evidence-informed guidance. Conclusion: The COVID-19 pandemic has created unprecedented challenges in IPM creating needless suffering for pain patients. Many IPM procedures cannot be indefinitely postponed without adverse consequences. Chronic pain exacerbations are associated with marked functional declines and risks with alternative treatment modalities. They must be treated with the concern that they deserve. Clinicians must assess patients, local healthcare resources, and weigh the risks and benefits of a procedure against the risks of suffering from disabling pain and exposure to the COVID-19 virus.
- Open Access
- 1 January 2015
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 6 (5) , 194-235
Comparison of the efficacy of saline, local anesthetics, and steroids in epidural and facet joint injections for the management of spinal pain: A systematic review of randomized controlled trials
The efficacy of epidural and facet joint injections has been assessed utilizing multiple solutions including saline, local anesthetic, steroids, and others. The responses to these various solutions have been variable and have not been systematically assessed with long-term follow-ups. Randomized trials utilizing a true active control design were included. The primary outcome measure was pain relief and the secondary outcome measure was functional improvement. The quality of each individual article was assessed by Cochrane review criteria, as well as the criteria developed by the American Society of Interventional Pain Physicians (ASIPP) for assessing interventional techniques. An evidence analysis was conducted based on the qualitative level of evidence (Level I to IV). A total of 31 trials met the inclusion criteria. There was Level I evidence that local anesthetic with steroids was effective in managing chronic spinal pain based on multiple high-quality randomized controlled trials. The evidence also showed that local anesthetic with steroids and local anesthetic alone were equally effective except in disc herniation, where the superiority of local anesthetic with steroids was demonstrated over local anesthetic alone. This systematic review showed equal efficacy for local anesthetic with steroids and local anesthetic alone in multiple spinal conditions except for disc herniation where the superiority of local anesthetic with steroids was seen over local anesthetic alone.
- 1 January 2015
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 6 (5) , 194-235
Open AccessComparison of the efficacy of saline, local anesthetics, and steroids in epidural and facet joint injections for the management of spinal pain: A systematic review of randomized controlled trials
The efficacy of epidural and facet joint injections has been assessed utilizing multiple solutions including saline, local anesthetic, steroids, and others. The responses to these various solutions have been variable and have not been systematically assessed with long-term follow-ups. Randomized trials utilizing a true active control design were included. The primary outcome measure was pain relief and the secondary outcome measure was functional improvement. The quality of each individual article was assessed by Cochrane review criteria, as well as the criteria developed by the American Society of Interventional Pain Physicians (ASIPP) for assessing interventional techniques. An evidence analysis was conducted based on the qualitative level of evidence (Level I to IV). A total of 31 trials met the inclusion criteria. There was Level I evidence that local anesthetic with steroids was effective in managing chronic spinal pain based on multiple high-quality randomized controlled trials. The evidence also showed that local anesthetic with steroids and local anesthetic alone were equally effective except in disc herniation, where the superiority of local anesthetic with steroids was demonstrated over local anesthetic alone. This systematic review showed equal efficacy for local anesthetic with steroids and local anesthetic alone in multiple spinal conditions except for disc herniation where the superiority of local anesthetic with steroids was seen over local anesthetic alone.
- 14 March 2012
- Published by American Medical Association (AMA)
- Vol. 307 (10) , 1087-1088
Central Pain Syndrome: Pathophysiology, Diagnosis, and Management
With Central Pain Syndrome, Sergio Canavero and Vincenzo Bonicalzi have produced a unique text on central pain. It contains one of the most extensive catalogs of studies on the subject available to researchers and clinicians today. The book creates a framework for understanding central pain and culminates with a discussion of the “attractor dynamic reverberation theory,” which the authors claim will “[offer] a definitive cure and [do] away with all competing theories.”
- 14 March 2012
- Published by American Medical Association (AMA)
- Vol. 307 (10) , 1087-1088
Central Pain Syndrome: Pathophysiology, Diagnosis, and Management
With Central Pain Syndrome, Sergio Canavero and Vincenzo Bonicalzi have produced a unique text on central pain. It contains one of the most extensive catalogs of studies on the subject available to researchers and clinicians today. The book creates a framework for understanding central pain and culminates with a discussion of the “attractor dynamic reverberation theory,” which the authors claim will “[offer] a definitive cure and [do] away with all competing theories.”
- 11 January 2012
- Published by American Medical Association (AMA)
- Vol. 307 (2) , 201-202
Essentials of Pain Medicine
In their preface to this text, Honorio Benzon and colleagues state that “Once reliant on drugs that were ineffective or saddled with numerous side effects, we now employ drugs that are effective and have minimal side effects. The next few years will bring about the use of receptor-specific medications. . . . Today, the use of ultrasound is generating intense interest. . . . To the patient suffering from pain, there is continued hope.” Essentials of Pain Medicine is able to engender that sense of hope in its readers. The editors have assembled an impressive list of 125 authors from academic, government, and private settings across the country. The text is divided into 9 sections: “Basic Considerations,” “Clinical Evaluation and Diagnostic Examinations,” “Pharmacology and Pharmacologic Modalities,” “Therapeutic Interventions,” “Perioperative Pain Management,” “Chronic Pain Syndromes,” “Interventional Techniques for Pain Management,” “Cancer Pain,” and “Nerve Blockade.”
- 11 January 2012
- Published by American Medical Association (AMA)
- Vol. 307 (2) , 201-202
Essentials of Pain Medicine
In their preface to this text, Honorio Benzon and colleagues state that “Once reliant on drugs that were ineffective or saddled with numerous side effects, we now employ drugs that are effective and have minimal side effects. The next few years will bring about the use of receptor-specific medications. . . . Today, the use of ultrasound is generating intense interest. . . . To the patient suffering from pain, there is continued hope.” Essentials of Pain Medicine is able to engender that sense of hope in its readers. The editors have assembled an impressive list of 125 authors from academic, government, and private settings across the country. The text is divided into 9 sections: “Basic Considerations,” “Clinical Evaluation and Diagnostic Examinations,” “Pharmacology and Pharmacologic Modalities,” “Therapeutic Interventions,” “Perioperative Pain Management,” “Chronic Pain Syndromes,” “Interventional Techniques for Pain Management,” “Cancer Pain,” and “Nerve Blockade.”
- 12 October 2011
- Published by American Medical Association (AMA)
- Vol. 306 (14) , 1602
Handbook of Pediatric Chronic Pain: Current Science and Integrative Practice
“The health of a nation is largely a reflection of the past and present health of its children . . . greater attention [must] be paid to . . . prevent the precursors of future adult health disorders.” So begins the Handbook of Pediatric Chronic Pain, edited by Brenda C. McClain and Santhanam Suresh. The book is organized into 23 chapters and draws on the expertise of 35 authors. The book underscores the importance of chronic pain and its relevance to clinicians treating pediatric as well as adult patients.
- 12 October 2011
- Published by American Medical Association (AMA)
- Vol. 306 (14) , 1602
Handbook of Pediatric Chronic Pain: Current Science and Integrative Practice
“The health of a nation is largely a reflection of the past and present health of its children . . . greater attention [must] be paid to . . . prevent the precursors of future adult health disorders.” So begins the Handbook of Pediatric Chronic Pain, edited by Brenda C. McClain and Santhanam Suresh. The book is organized into 23 chapters and draws on the expertise of 35 authors. The book underscores the importance of chronic pain and its relevance to clinicians treating pediatric as well as adult patients.
- 1 May 2009
- Published by Oxford University Press (OUP) in Pain Medicine
- Vol. 10 (4) , 716-721
Pain and Prejudice
Background. The primary objective of this pilot study is to understand the relationship between physicians' characteristics and physicians' management decisions about pain. The secondary aim is to understand how patient characteristics, including race/ethnicity and socioeconomic status (SES) may affect these treatment decisions in chronic low back pain. Methods. We conducted a double-blinded randomized controlled study using a survey instrument. Ninety physicians were randomly allocated one of two scenarios of a patient with chronic low back and lower extremity pain. In one version, the patient is a Caucasian male with Blue Cross health insurance. In the other version, the patient is an African American male with Medicaid. All other aspects of the survey scenarios are identical. The physicians were subsequently presented with questionnaires about their treatment plans. We analyzed the physician demographic variables in addition to patient ethnicity and SES to differentiate which variables affected treatment preferences. Results. Based on bivariate analysis, physician specialty, gender, ethnicity, and professional status significantly affected treatment plans, including analgesic prescription and referrals for invasive therapy. Patient ethnicity/SES trended toward significance for the prescription of opioids. Conclusion. Our study is the first randomized controlled study assessing patient and treatment variables in the management of chronic pain. It suggests that physicians' demographic variables and perhaps patient demographic variables influence pain management decisions.
- 1 May 2009
- Published by Oxford University Press (OUP) in Pain Medicine
- Vol. 10 (4) , 716-721
Pain and Prejudice
Background. The primary objective of this pilot study is to understand the relationship between physicians' characteristics and physicians' management decisions about pain. The secondary aim is to understand how patient characteristics, including race/ethnicity and socioeconomic status (SES) may affect these treatment decisions in chronic low back pain. Methods. We conducted a double-blinded randomized controlled study using a survey instrument. Ninety physicians were randomly allocated one of two scenarios of a patient with chronic low back and lower extremity pain. In one version, the patient is a Caucasian male with Blue Cross health insurance. In the other version, the patient is an African American male with Medicaid. All other aspects of the survey scenarios are identical. The physicians were subsequently presented with questionnaires about their treatment plans. We analyzed the physician demographic variables in addition to patient ethnicity and SES to differentiate which variables affected treatment preferences. Results. Based on bivariate analysis, physician specialty, gender, ethnicity, and professional status significantly affected treatment plans, including analgesic prescription and referrals for invasive therapy. Patient ethnicity/SES trended toward significance for the prescription of opioids. Conclusion. Our study is the first randomized controlled study assessing patient and treatment variables in the management of chronic pain. It suggests that physicians' demographic variables and perhaps patient demographic variables influence pain management decisions.
- Top Cited Papers
- 13 August 2008
- Published by American Medical Association (AMA) in JAMA
- Vol. 300 (6) , 711-719
Prevalence of Chronic Pain After Traumatic Brain Injury
Review from JAMA — Prevalence of Chronic Pain After Traumatic Brain Injury — A Systematic Review
- 13 August 2008
- Published by American Medical Association (AMA) in JAMA
- Vol. 300 (6) , 711-719
Top Cited PapersPrevalence of Chronic Pain After Traumatic Brain Injury
Review from JAMA — Prevalence of Chronic Pain After Traumatic Brain Injury — A Systematic Review
- 31 May 2008
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 14 (4) , 356-358
Inpatient rehabilitation after deep brain stimulator placement: A case series
- 31 May 2008
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 14 (4) , 356-358
Inpatient rehabilitation after deep brain stimulator placement: A case series
- 1 January 2008
- Published by Wolters Kluwer Health in Cornea
- Vol. 27 (1) , 124-126
Topiramate for the Treatment of Chronic Corneal Pain
To explore the option of using anticonvulsant drugs to modulate pain from corneal erosions. N.M. is a 28-year-old woman with posttraumatic recurrent corneal erosions treated with bandage contact lenses, Muro-128, topical ketorolac, doxycycline, stromal micropuncture, and laser epithelial keratomileusis over the course of 4 years. Because of persistent episodes of corneal pain, she was prescribed topiramate. Before starting topiramate therapy, N.M. had experienced 3-4 awakenings at night because of pain and 5-6 episodes of spontaneous tearing and pain during the day. She started topiramate at 25 mg orally 4 times a day without significant change in her symptoms. After 1 week, the dose was escalated to 50 mg orally 4 times a day, and within 1 day, she experienced 0-1 awakenings at night. She had approximately 2-3 episodes of pain and tearing during the day. The dose was escalated to 100 mg orally 4 times a day. At that dose, the patient continued to have pain relief but complained of nausea. The patient's topiramate was weaned off to determine whether her symptom relief was caused by the medication or improvement in her condition. Once off the topiramate, N.M.'s nausea resolved but her corneal symptoms returned at the same frequency as before the initiation of topiramate. Therefore, she was restarted on topiramate 50 mg orally 4 times a day with rapid onset of improvement in her symptoms. Anticonvulsants such as topiramate may be effective in the management of pain caused by recurrent corneal erosions.
- 1 January 2008
- Published by Wolters Kluwer Health in Cornea
- Vol. 27 (1) , 124-126
Topiramate for the Treatment of Chronic Corneal Pain
To explore the option of using anticonvulsant drugs to modulate pain from corneal erosions. N.M. is a 28-year-old woman with posttraumatic recurrent corneal erosions treated with bandage contact lenses, Muro-128, topical ketorolac, doxycycline, stromal micropuncture, and laser epithelial keratomileusis over the course of 4 years. Because of persistent episodes of corneal pain, she was prescribed topiramate. Before starting topiramate therapy, N.M. had experienced 3-4 awakenings at night because of pain and 5-6 episodes of spontaneous tearing and pain during the day. She started topiramate at 25 mg orally 4 times a day without significant change in her symptoms. After 1 week, the dose was escalated to 50 mg orally 4 times a day, and within 1 day, she experienced 0-1 awakenings at night. She had approximately 2-3 episodes of pain and tearing during the day. The dose was escalated to 100 mg orally 4 times a day. At that dose, the patient continued to have pain relief but complained of nausea. The patient's topiramate was weaned off to determine whether her symptom relief was caused by the medication or improvement in her condition. Once off the topiramate, N.M.'s nausea resolved but her corneal symptoms returned at the same frequency as before the initiation of topiramate. Therefore, she was restarted on topiramate 50 mg orally 4 times a day with rapid onset of improvement in her symptoms. Anticonvulsants such as topiramate may be effective in the management of pain caused by recurrent corneal erosions.